Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials
Diabetes Therapy - United States
doi 10.1007/s13300-019-00699-8
Full Text
Open PDFAbstract
Available in full text
Date
October 12, 2019
Authors
Publisher
Springer Science and Business Media LLC